Jennison Associates LLC Pro Qr Therapeutics N.V. Transaction History

Jennison Associates LLC

$160 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$0.9 - $8.39 $1.63 Million - $15.2 Million	-1,814,330 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$6.58 - $8.44 $179,291 - $229,973	-27,248 Reduced 1.48%	1,814,330 $14.5 Million
Q3 2021 Nov 09, 2021	SELL	$5.16 - $8.47 $3.92 Million - $6.43 Million	-758,849 Reduced 29.18%	1,841,578 $15.4 Million
Q1 2021 May 11, 2021	SELL	$4.14 - $9.22 $66,430 - $147,944	-16,046 Reduced 0.61%	2,600,427 $17.2 Million
Q4 2020 Feb 05, 2021	SELL	$3.58 - $4.85 $63,247 - $85,684	-17,667 Reduced 0.67%	2,616,473 $11 Million
Q3 2020 Nov 04, 2020	BUY	$4.79 - $6.3 $41,318 - $54,343	8,626 Added 0.33%	2,634,140 $12.6 Million
Q2 2020 Aug 06, 2020	BUY	$4.5 - $6.53 $59,436 - $86,248	13,208 Added 0.51%	2,625,514 $16 Million
Q1 2020 May 06, 2020	SELL	$5.25 - $9.9 $96,180 - $181,368	-18,320 Reduced 0.7%	2,612,306 $14.3 Million
Q4 2019 Feb 07, 2020	BUY	$5.84 - $10.51 $67,825 - $122,063	11,614 Added 0.44%	2,630,626 $26.1 Million
Q3 2019 Nov 08, 2019	SELL	$5.76 - $9.44 $1.32 Million - $2.17 Million	-229,916 Reduced 8.07%	2,619,012 $15.1 Million
Q2 2019 Aug 06, 2019	SELL	$9.1 - $15.55 $360,951 - $616,790	-39,665 Reduced 1.37%	2,848,928 $0
Q1 2019 May 10, 2019	SELL	$12.5 - $18.48 $1.33 Million - $1.97 Million	-106,712 Reduced 3.56%	2,888,593 $40.1 Million
Q4 2018 Feb 06, 2019	SELL	$15.25 - $22.4 $42,532 - $62,473	-2,789 Reduced 0.09%	2,995,305 $47.3 Million
Q3 2018 Nov 08, 2018	BUY	$6.45 - $21.6 $108,934 - $364,802	16,889 Added 0.57%	2,998,094 $58 Million
Q2 2018 Aug 02, 2018	BUY	$2.95 - $7.45 $90,951 - $229,690	30,831 Added 1.04%	2,981,205 $21.8 Million
Q1 2018 Apr 20, 2018	BUY	$2.9 - $3.5 $912,983 - $1.1 Million	314,822 Added 11.95%	2,950,374 $9.07 Million
Q4 2017 Jan 25, 2018	BUY	$2.8 - $4.8 $498,937 - $855,321	178,192 Added 7.25%	2,635,552 $8.5 Million
Q3 2017 Nov 03, 2017	BUY	$4.35 - $6.45 $10.7 Million - $15.8 Million	2,457,360	2,457,360 $11.9 Million

Others Institutions Holding PRQR

# of Institutions

Shares Held

17.4M

Call Options Held

37.7K

Put Options Held

21.3K

Privium Fund Management B.V.

5.63M
Shares

$15 Million
2.56% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

3.63M
Shares

$9.68 Million
0.01% of portfolio
Eco R1 Capital, LLC San Francisco, CA

1.84M
Shares

$4.9 Million
0.14% of portfolio
M28 Capital Management LP Stamford, CT

1.02M
Shares

$2.72 Million
1.76% of portfolio
Dafna Capital Management LLC Los Angeles, CA

906K
Shares

$2.42 Million
0.42% of portfolio

View Full List

About ProQR Therapeutics N.V.

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $191M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

More about PRQR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account